FENNEC PHARMACEUTICALS INC's ticker is FENC and the CUSIP is 31447P100. A total of 57 filers reported holding FENNEC PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.43 and the average weighting 0.6%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $3,169 | +173.9% | 422 | +222.1% | 0.00% | – |
Q2 2023 | $1,157 | -37.9% | 131 | -41.5% | 0.00% | – |
Q1 2023 | $1,864 | +73.4% | 224 | +100.0% | 0.00% | – |
Q4 2022 | $1,075 | +7.5% | 112 | 0.0% | 0.00% | – |
Q3 2022 | $1,000 | 0.0% | 112 | 0.0% | 0.00% | – |
Q2 2022 | $1,000 | 0.0% | 112 | 0.0% | 0.00% | – |
Q1 2022 | $1,000 | – | 112 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Sonic GP LLC | 2,407,357 | $18,079,251 | 17.55% |
Solas Capital Management, LLC | 1,725,567 | $12,959,008 | 9.07% |
DG Capital Management, LLC | 1,143,099 | $8,584,673 | 4.70% |
HARBERT FUND ADVISORS, INC. | 466,869 | $3,506,186 | 2.56% |
AIGH Capital Management LLC | 373,526 | $2,805,180 | 1.33% |
Southpoint Capital Advisors LP | 4,077,214 | $30,619,877 | 0.68% |
APIS CAPITAL ADVISORS, LLC | 70,000 | $525,700 | 0.68% |
Worth Venture Partners, LLC | 92,636 | $695,696 | 0.41% |
Lion Point Capital, LP | 110,000 | $826,100 | 0.37% |
683 Capital Management, LLC | 300,000 | $2,253,000 | 0.18% |